These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12632553)

  • 1. Diabetes medicine update. Old dogs, new tricks.
    Nakamoto M
    Diabetes Self Manag; 2003; 20(1):14-5. PubMed ID: 12632553
    [No Abstract]   [Full Text] [Related]  

  • 2. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 3. New labeling and use changes for Rezulin.
    Klonoff DC
    Diabetes Technol Ther; 1999; 1(3):350. PubMed ID: 11484719
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination therapy in type 2 diabetes: the role of repaglinide.
    Moses R
    J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes drug Rezulin: take it, but take precautions.
    Health News; 1999 May; 5(6):7. PubMed ID: 10546576
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.
    Kohlroser J; Mathai J; Reichheld J; Banner BF; Bonkovsky HL
    Am J Gastroenterol; 2000 Jan; 95(1):272-6. PubMed ID: 10638596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warner-Lambert voluntarily withdraws Rezulin.
    Diabetes Technol Ther; 2000; 2(2):290. PubMed ID: 11469273
    [No Abstract]   [Full Text] [Related]  

  • 8. Metaglip and Avandamet for type 2 diabetes.
    Med Lett Drugs Ther; 2002 Dec; 44(1146):107-9. PubMed ID: 12500153
    [No Abstract]   [Full Text] [Related]  

  • 9. Update in endocrinology.
    Whitcomb RW
    Ann Intern Med; 1998 May; 128(10):871. PubMed ID: 9599203
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.
    Gorman C
    Time; 2000 Apr; 155(13):94. PubMed ID: 11009709
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients with both diabetes and heart failure often treated with medications government considers unsafe.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Aug; 14(15):1, 6-7. PubMed ID: 12964577
    [No Abstract]   [Full Text] [Related]  

  • 12. Advisory panel hears contradictory evidence, backs keeping troglitazone on market.
    Miller JL
    Am J Health Syst Pharm; 1999 May; 56(9):840, 842. PubMed ID: 10344603
    [No Abstract]   [Full Text] [Related]  

  • 13. [Are PPAR-gamma-agonists a secure choice in treatment of overweight diabetic patients?].
    Larsen PJ
    Ugeskr Laeger; 2000 Aug; 162(32):4280-1. PubMed ID: 10962950
    [No Abstract]   [Full Text] [Related]  

  • 14. How should patients taking the discontinued diabetes drug troglitazone be managed?
    Reddy SS
    Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221
    [No Abstract]   [Full Text] [Related]  

  • 15. Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.
    Diabetes Technol Ther; 2000; 2(2):292. PubMed ID: 11469275
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug recalls underscore safety concerns.
    Greene HL
    Health News; 2000 May; 6(5):4. PubMed ID: 10851966
    [No Abstract]   [Full Text] [Related]  

  • 17. Pioglitazone-associated fulminant hepatic failure.
    Chase MP; Yarze JC
    Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
    [No Abstract]   [Full Text] [Related]  

  • 18. Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.
    Diabetes Technol Ther; 2000; 2(2):290-1. PubMed ID: 11469274
    [No Abstract]   [Full Text] [Related]  

  • 19. Glitazones and NIDDM.
    Sakane N; Yoshida T; Kondo M
    Lancet; 1997 Mar; 349(9056):952. PubMed ID: 9093269
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin-sensitizing agent].
    Yamanouchi T
    Nihon Rinsho; 1999 Mar; 57(3):675-80. PubMed ID: 10199153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.